Literature DB >> 9737668

Differential effect on TCR:CD3 stimulation of a 90-kD glycoprotein (gp90/Mac-2BP), a member of the scavenger receptor cysteine-rich domain protein family.

B Silvestri1, F Calderazzo, V Coppola, A Rosato, S Iacobelli, C Natoli, A Ullrich, I Sures, M Azam, C Brakebush, L Chieco-Bianchi, A Amadori.   

Abstract

We studied the effects of a 90-kD glycoprotein (gp90/Mac-2BP) belonging to the scavenger receptor family, present in normal serum and at increased levels in inflammatory disease and cancer patients, on some T cell function parameters. Whereas the lymphocyte proliferative response to non-specific mitogens such as phytohaemagglutinin (PHA) and concanavalin A (Con A), but not pokeweed mitogen (PWM), was strongly reduced, probably due to the lectin-binding properties of gp90/Mac-2BP, the response to T cell receptor (TCR) agonists such as superantigens and allogeneic cells was potentiated. When lymphocytes were stimulated with different anti-TCR:CD3 MoAbs, both in soluble and solid-phase form, gp90/Mac-2BP was able to down-regulate the proliferative response to anti-CD3 MoAb, whereas the response to anti-TCR alphabeta MoAb was enhanced. A similar differential effect was observed when a MoAb against CD5 (another member of the scavenger receptor superfamily) was added to anti-CD3 or anti-TCR-stimulated cells; anti-CD5 MoAb strongly down-modulated the CD3-mediated response, whereas its presence in culture was associated with potentiation of the response to TCR alphabeta agonists. gp90/Mac-2BP was able per se to up-regulate Ca2+ levels in freshly isolated lymphocytes; moreover, its presence in culture was associated with increased Ca2+ mobilization following stimulation with anti-TCR alphabeta, but not anti-CD3 MoAb. These data indicate that gp90/Mac-2BP could be able to influence some immune responses, possibly through multiple homologous interactions with other members of the scavenger receptor family; moreover, our findings suggest that signalling through the different components of the TCR:CD3 complex may follow distinct activation pathways into the cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737668      PMCID: PMC1905063          DOI: 10.1046/j.1365-2249.1998.00654.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  TCR-CD4 and TCR-TCR interactions as distinctive mechanisms for the induction of increased intracellular calcium in T-cell signalling.

Authors:  C H Wolff; S C Hong; H von Grafenstein; C A Janeway
Journal:  J Immunol       Date:  1993-08-01       Impact factor: 5.422

3.  Galectins: a family of animal beta-galactoside-binding lectins.

Authors:  S H Barondes; V Castronovo; D N Cooper; R D Cummings; K Drickamer; T Feizi; M A Gitt; J Hirabayashi; C Hughes; K Kasai
Journal:  Cell       Date:  1994-02-25       Impact factor: 41.582

4.  90K (Mac-2 BP) in human milk.

Authors:  N D'Ostilio; G Sabatino; C Natoli; A Ullrich; S Iacobelli
Journal:  Clin Exp Immunol       Date:  1996-06       Impact factor: 4.330

5.  A 90-kDa protein serum marker for the prediction of progression to AIDS in a cohort of HIV-1+ homosexual men.

Authors:  N C Briggs; C Natoli; N Tinari; M D'Egidio; J J Goedert; S Iacobelli
Journal:  AIDS Res Hum Retroviruses       Date:  1993-09       Impact factor: 2.205

6.  Cloning and characterization of cyclophilin C-associated protein: a candidate natural cellular ligand for cyclophilin C.

Authors:  J Friedman; M Trahey; I Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

7.  Prognostic value of a novel circulating serum 90K antigen in HIV-infected haemophilia patients.

Authors:  G Longo; C Natoli; D Rafanelli; N Tinari; M Morfini; P Rossi-Ferrini; N D'Ostilio; S Iacobelli
Journal:  Br J Haematol       Date:  1993-09       Impact factor: 6.998

8.  Cloning and expression of a mouse macrophage cDNA coding for a membrane glycoprotein of the scavenger receptor cysteine-rich domain family.

Authors:  Y Chicheportiche; P Vassalli
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

9.  Dynamic test with recombinant interferon-alpha-2b: effect on 90K and other tumour-associated antigens in cancer patients without evidence of disease.

Authors:  C Natoli; C Garufi; N Tinari; M D'Egidio; G Lesti; L A Gaspari; R Visini; S Iacobelli
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

10.  Prognostic value of a novel circulating serum 90K antigen in breast cancer.

Authors:  S Iacobelli; P Sismondi; M Giai; M D'Egidio; N Tinari; C Amatetti; P Di Stefano; C Natoli
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

View more
  5 in total

1.  Elevated levels of circulating immunostimulatory 90K in Henoch-Schoenlein purpura.

Authors:  P Pelliccia; C Natoli; M T Petitti; A Verrotti; F Chiarelli; S Iacobelli
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

2.  LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis.

Authors:  Enza Piccolo; Nicola Tinari; Daniela Semeraro; Sara Traini; Imma Fichera; Albana Cumashi; Rossana La Sorda; Francesca Spinella; Anna Bagnato; Rossano Lattanzio; Maurizia D'Egidio; Annalisa Di Risio; Pavlos Stampolidis; Mauro Piantelli; Clara Natoli; Axel Ullrich; Stefano Iacobelli
Journal:  J Mol Med (Berl)       Date:  2012-08-05       Impact factor: 4.599

3.  Lgals3bp suppresses colon inflammation and tumorigenesis through the downregulation of TAK1-NF-κB signaling.

Authors:  Sang-Hee Cho; Hyun-Jeong Shim; Mi-Ra Park; Ji-Na Choi; Md Rashedunnabi Akanda; Jun-Eul Hwang; Woo-Kyun Bae; Kyung-Hwa Lee; Eun-Gene Sun; Ik-Joo Chung
Journal:  Cell Death Discov       Date:  2021-04-06

4.  LGALS3BP in Microglia Promotes Retinal Angiogenesis Through PI3K/AKT Pathway During Hypoxia.

Authors:  Chenyang Zhao; Yusen Liu; Jiayu Meng; Xiaotang Wang; Xianyang Liu; Wanqian Li; Qian Zhou; Junjie Xiang; Na Li; Shengping Hou
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-07-08       Impact factor: 4.925

5.  Prognostic relevance of LGALS3BP in human colorectal carcinoma.

Authors:  Enza Piccolo; Nicola Tinari; Domenica D'Addario; Cosmo Rossi; Valentina Iacobelli; Rossana La Sorda; Rossano Lattanzio; Maurizia D'Egidio; Annalisa Di Risio; Mauro Piantelli; Pier Giorgio Natali; Stefano Iacobelli
Journal:  J Transl Med       Date:  2015-07-30       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.